Mutations in the TP53 gene often result in the accumulation of stable protein that exhibits a gain-of-function (GOF) phenotype, where mutant p53 loses its function as a tumor suppressor and acquires new oncogenic features independent of wild-type p53 function11,13. This evidence concerns the gene TP53 and neoplasm.